Nuclei were prepared by sucrose sedimentation of liver homogenates from rats given l25I-labeled triiodothyronine in vivo. The nuclear extract obtained by treatment of the nuclear pellet with 0.4 M KC1 contains the ['25l]triiodothyronine that had been injected in vivo bound to protein(s). The triiodothyronine bound to nuclear protein(s) in vivo does not readily exchange with triiodothyronine added to the extract in vitro. This triiodothyronine-nuclear extract complex retains triiodothyronine during dialysis or exposure to anion exchange resin and migrates as a broad band on agarose-gel electrophoresis. It is rapidly destroyed by Pronase, by 8 M urea, and by p-chloromercuribenzoic acidl, but not by RNase or by DNase. It is also susceptible to thermal inactivation at 370, possibly through changes in the affinity of triiodothyronine to the nuclear binding protein(s), since the bound triiodothyronine becomes more readily dialyzable, is absorbed by an anion exchange resin, but retains its characteristic mobility on electrophoresis. The triiodothyronine*nuclear extract complex formed in vivo binds to crude liver chromatin in vitro at low salt concentration, but can be completely extracted again at KC1 concentrations greater than 0.2 M.
Accumulation of labeled triiodothyronine (T3) in the nuclei of rat liver and kidney and in pituitary tissue has been reported by Oppenheimer and coworkers (1, 2) . We have reported similar studies performed on rats given [1251I]T3 in vivo.
Nuclear pellets were prepared from liver homogenate by sucrose gradient centrifugation. Nuclei of normal rats contained 10% of the total hormone present in the liver homogenate 2 hr after injection of the tracer, and twice as much was found in nuclei from hypothyroid animals (3). The [1251 ]T3 was readily displaced from the nuclei by administration of unlabeled T3 and triiodothyroacetic acid in vivo, but less effectively by L-or D-thyroxine. Binding capacity determined in vivo was 2.4 ng of T3 per g of liver. Half of the [125I]T3 present in nuclei after administration of hormone in vivo could be extracted by a single treatment of the nuclei with 0.4 M KCL. The [1251 ]T3 complex in this extract behaved as a macromolecule(s) with an approximate 4S sedimentation constant and was destroyed by treatment with Pronase, but not by RNase or by DNase. These studies indicated that the nuclear T3-binding material is a protein and that it is partially saturated at normal levels of serum T3 in the rat.
We have conducted further studies on the nature of the nuclear Tr-binding material using electrophoretic, resin uptake, and dialysis procedures, and have studied its binding to rat liver chromatin.
MATERIALS AND METHODS
Charles River male rats of 75-100 g were given an intravenous injection of 1-100 MCi of [1251 ]T3 (100 mCi/mg, Industrial Nuclear Co., St. Louis, Mo.) and killed 2 hr later. Liver was homogenized in 0.32 M sucrose plus 1 mM MgCl2, and the homogenate was centrifuged at 1000 X g for 15 min. The sediment was washed once with sucrose-MgCl2 and centrifuged through 2.3 M sucrose plus 1 mM MgCl2 in the SW-65 head of a Spinco ultracentrifuge at 37,500 rpm for 30 min.
The pellet was resuspended in 0.32 M sucrose-1 mM MgC12 and washed by centrifugation at 1000 X g for 15 min. All procedures were carried out at 0-2°. Aliquots of the nuclear pellet were resuspended in sucroseMgCl2, 0.4 M KCl-1 mM MgCl2-5 mM potassium phosphate (pH 7.4) buffer, 50 mM Tris-glycine buffer (pH 8.6)-25 mM KC1-5 mM MgCl2, or 50 mM Tris-chloride buffer (pH 7.4)-25 mM KC1-5 mM MgCl2-0.32 M sucrose. After incubation in ice for 30 min and at 370 for 2 min the suspensions were centrifuged at 100,000 X g for 45 min. Extracts with sucroseMgCl2 contained 0-2% of the nusclear pellet radioactivity, those with KC1-MgCl2-potassium phosphate and Tris-glycine-KCl-MgCl2 40-60%, and those with Tris. Cl-KClMgCl2-sucrose 50-70%. Final KCl-MgCl2-potassium phosphate extracts recovered 500-700 ,ug of protein and 30 gsg of DNA per g of liver. Most of the data to be presented below were obtained with KCl-MgC12-potassium phosphate nuclear extracts, although qualitatively similar results have been obtained with nuclear extracts prepared with either Tris-glycine-KCl-MgCl2 or Tris-Cl-KCl-MgCl2-sucrose. Nuclear extracts were kept at 0-20 except during the manipulation discussed below, and were used within 48 hr of preparation. tubes. Two were retained for determination of total radioactivity and two were treated with resin. A quaternary amine anion exchange resin (0.5 ml; Rexyn 201, Fisher Scientific Co.) was rapidly added to the appropriate tubes, which were then shaken in ice at three strokes per see for 2 min. The volume was brought to 4 ml by addition of KCl-MgCl2-potassium phosphate, and 2-ml aliquots of the supernatant were removed for determination of isotope content. Duplicate tubes prepared for determination of total counts were similarly treated except for the addition of resin (4 Electrophoresis of the nuclear extract containing labeled T3 given in vivo or added in vitro was carried out in a Laurell-type agarose-gel electrophoresis system, in Tris-maleate buffer (pH 8.6), plus 20 mM KCI. Electrophoresis was for 1.3-1.5 hr at 2-4o, 150 V, and 150 mA. At the completion of each electrophoresis, the agarose was immediately cut into 0.5-cm sections, and the isotope content was determined in a well-type scintillation gamma spectrometer (5).
The ability of the ['31I]T3-nuclear extract complex formed in vivo to bind to chromatin was assessed in a system described by Spelsberg et al. (6) . Crude chromatin, containing 200, 44, and 240.ug of DNA, RNA, and proteins per ml, respectively, was prepared from rat liver. Aliquots containing 10 /Ag of DNA in sucrose-MgCl2 plus 5 mM potassium phosphate buffer (pH 7.4) were added to plastic tubes in a volume of 0.05 ml.
Various amounts of KCl were added to sets of duplicate tubes to bring the final concentration from 0.01 to 0.61 M in a volume 0.4 ml completed with sucrose-MgCl2-potassium phosphate. The incubation mixture also contained 0.03 ml of a KCl-MgCl2-potassium phosphate nuclear extract of liver prepared from rats given [13111]T3 (250 ng) in vivo 2 hr before they were killed. All tubes were incubated with shaking in ice for 1 hr. At the termination of the incubation period the tubes were centrifuged at 1000 X g for 15 min, the supernatant was aspirated, and the residue was washed once with 4 ml of iced sucrose-MgCl2-potassium phosphate. After resedimentation and withdrawal of the supernatant, residual radioactivity was counted in a well scintillation gamma spectrometer. In parallel studies [1111IT3 and 1'"I-labeled serum albumin, added to chromatin, and [1311]T3-labeled nuclear extract without chromatin, were incubated and analyzed under identical conditions.
RESULTS
Aliquots of nuclear extract containing [1251IT3 given in vivo were incubated with anion exchange resin on the assumption that the resin would bind T3 free in solution and/or remove some T3 from its binding site(s) if the nuclear extract behaved as do serum or cytosol binding proteins (4, (7) (8) (9) (10) . About 44% of [1251IT3 present in nuclear extract derived from rats given the hormone in vivo, and 2.5-10% of ['"lI]T3 added in vitro to the nuclear extract 6 hr before exposure to resin, remained in the supernatant (Fig. 1) . Similarly, in the absence of nuclear extract, 2-5% of T3 added in KCl-MgCl2-potassium phos- in vivo. Dithiothreitol at 0.1 mM had no effect, but did completely prevent the destructive effect of p-chloromercuribenzoate. Preincubation of the [26I ]T3-nuclear extract complex-formed in vivo with Pronase displaced the label to the resin, while similar incubations with RNase and DNase did not. Urea (8 M) partially depressed the retention of [12" lIT, by the nuclear extract (Fig. 1) Fig. 2 ) did not affect the electrophoretic pattern (bands as in Fig. 2B ). The proportion of nondialyzable isotope, or that remaining in the supernatant after resin treatment (Fig. 1) , and thus bound in vivo to the nuclear extract, correlated (with the exception of heat-treated nuclear extract as discussed below) with the fraction of the isotope migrating in band 2 on agarose-gel electrophoresis.
To study the affinity of T3-nuclear extract complex for chromatin, we incubated aliquots of a crude liver chromatin preparation (6) containing 10 jyg of DNA with [125I]T3-nuclear extract complex formed in vivo. In control studies, ["1lIT3 and "3'I-labeled serum albumin were added in place of the [13lI]T3-nuclear extract complex, and the latter was incubated without chromatin. Forty to 70% of [l25IT, nuclear extract complex (depending on the nuclear extract preparation and amount of chromatin) was retained by the chromatin at concentrations of KCl less than 0.02 M. Eighteen to 20% of the isotope was retained above 0.2 M KCl, possibly representing nonspecific binding of free T3 present in the nuclear extract. Fifteen to 20% of ["3lI]T3 added to the nuclear extract in vitro and 5% of "'I-labeled serum albumin were retained, but this binding was the same at all KCl concentrations (Fig. 3) . The ["25 ]T3. nuclear extract complex was not retained in a KCl-sensitive manner in the absence of chromatin. Heating the complex at 370 for 10 tered by short-term exposure to 37°, in contrast to the effect demonstrated by dialysis and by resin procedure. The reason for this different behavior is unknown, but may be related to differences in the affinity of T3 for the nuclear binding protein or differences in buffers. It has been previously shown that the resin used in the assay can extract T3 bound to human serum albumin with a Ka of 106 M-', but not T3 from thyroxine-binding globulin or prealbumin, which have a Ka of 1010 and 108 M-, respectively. In the electrophoretic system used, however, T3 remains associated with albumin. Furthermore, it is also known that certain buffers, such as barbital, can displace thyroxine from prealbumin and allow its association with the resin (4). It is, therefore, possible that the heattreated nuclear extract retains some ability to bind T3 during electrophoresis but loses its original high affinity characteristic, as shown by the greater susceptibility of the T3 to dialysis and uptake by the resin.
Since the T3 nuclear extract complex formed in vivo is extractable from the nuclei with 0.4 M KC1 or other salt-containing solutions, it is logical to consider that it may exist in a complex with chromatin, which can be dissociated by the saltcontaining solutions. It has been demonstrated that the cytosol estrogen-binding protein (11, 12) and the cytosol progesterone-binding protein (13) can complex to chromatin, and that the complex is sensitive to salt concentration, mimicking the extraction procedure of nuclei after administration of the labeled hormone in vivo. We have found the same behavior to pertain for our [2J5I]T4 nuclear extract complex, which reassociates with chromatin in vitro at low salt concentrations and can be dissociated frQm it at KC1 concentrations above 0.2 M. At lower KC1 concentrations the behavior of the [12I]T3V nuclear extract complex formed in vivo is entirely distinct from the behavior of T3 added in vitro or of "'IIlabeled serum albumin, indicating that there is a specificity in binding of the complex formed in vivo to chromatin.
Our studies suggest the presence of a T3 protein complex in liver nuclei that is probably bound to chromatin. The complex is distinct from that formed by typical serum or cytosol binding proteins, since it is -not readily exchangeable by the addition of hormone in vitro, is very heat-sensitive, and has an essential sulfhydryl group. The present data do not prove that the T3 nuclear extract complex has physiologic importance in the molecular events produced by administration of T3. However, our results are consistent with the concept that T3 may have a function in transcription of genetic information in the nucleus (14, 15) . They are in agreement and extend the observations recently presented by Samuels and Tsai (16) and by Surks et al. (17) .
